Wealth Alliance Advisory Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
2,345
+63
+3% +$8.3K 0.04% 158
2026
Q1
$318K Buy
2,282
+5
+0.2% +$700 0.05% 157
2025
Q4
$279K Sell
2,277
-105
-4% -$12.8K 0.05% 165
2025
Q3
$264K Hold
2,382
0.05% 162
2025
Q2
$264K Hold
2,382
0.05% 161
2025
Q1
$267K Hold
2,382
0.06% 158
2024
Q4
$220K Buy
+2,382
New +$214K 0.05% 175
2023
Q2
Sell
-2,423
Closed -$201K 178
2023
Q1
$201K Sell
2,423
-135
-5% -$11.2K 0.08% 149
2022
Q4
$220K Sell
2,558
-865
-25% -$68.5K 0.08% 143
2022
Q3
$211K Buy
+3,423
New +$216K 0.09% 131
2022
Q2
Sell
-4,058
Closed -$241K 149
2022
Q1
$241K Sell
4,058
-61
-1% -$3.9K 0.1% 129
2021
Q4
$299K Hold
4,119
0.13% 115
2021
Q3
$288K Hold
4,119
0.14% 109
2021
Q2
$284K Hold
4,119
0.14% 112
2021
Q1
$266K Buy
+4,119
New +$266K 0.14% 115
2020
Q2
Sell
-2,768
Closed -$207K 130
2020
Q1
$207K Buy
+2,768
New +$191K 0.16% 102
2018
Q4
Sell
-4,050
Closed -$313K 127
2018
Q3
$313K Buy
4,050
+100
+3% +$7.55K 0.16% 98
2018
Q2
$280K Sell
3,950
-650
-14% -$45.9K 0.15% 95
2018
Q1
$347K Buy
+4,600
New +$366K 0.2% 74

Other funds holding GILD

Wealth Alliance Advisory Group's GILD Position: Q2 2026 in Review

Wealth Alliance Advisory Group increased its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, buying an estimated $8.3K and bringing the position to 2,345 shares worth $296K. The position accounts for 0.04% of the portfolio, ranked #158.

Wealth Alliance Advisory Group first reported a position in GILD in Q1 2018 and has held it in 19 quarters since. The position peaked at $347K in Q1 2018. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Alliance Advisory Group held 2,345 shares of Gilead Sciences worth $296K as of Q2 2026.
  • Wealth Alliance Advisory Group bought 63 Gilead Sciences shares in Q2 2026, an estimated $8.3K.
  • Gilead Sciences made up 0.04% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #158 holding.
  • Wealth Alliance Advisory Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 19 quarters since.
  • Wealth Alliance Advisory Group's Gilead Sciences position peaked at $347K in Q1 2018.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.